Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) - Total Assets
Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) holds total assets worth CN¥18.38 Billion CNY (≈ $2.69 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Zhangzhou Pientzehuang Pharmaceutical Co (600436) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Total Assets Trend (2000–2025)
This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore 600436 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total assets of CN¥18.38 Billion consist of 60.8% current assets and 39.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.2% |
| Accounts Receivable | CN¥753.17 Million | 4.3% |
| Inventory | CN¥6.68 Billion | 38.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥267.49 Million | 1.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 600436 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhangzhou Pientzehuang Pharmaceutical Co Ltd's current assets represent 60.8% of total assets in 2025, a decrease from 76.0% in 2000.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, up from 2.3% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 38.0% of total assets.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AstraZeneca PLC
LSE:AZN
|
UK | GBX114.02 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $136.46 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$207.62 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $207.62 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
|
China | CN¥892.78 Million |
|
Korean Drug Co. Ltd
KQ:014570
|
Korea | ₩95.05 Billion |
|
Chorokbaem Healthcare Co Ltd
KO:118000
|
Korea | ₩197.96 Billion |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.02 | 5.24 | 4.97 |
| Quick Ratio | 2.26 | 3.11 | 3.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥9.15 Billion | CN¥9.85 Billion | CN¥7.21 Billion |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.60 |
| Latest Market Cap to Assets Ratio | 0.57 |
| Asset Growth Rate (YoY) | 0.1% |
| Total Assets | CN¥17.56 Billion |
| Market Capitalization | $9.97 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhangzhou Pientzehuang Pharmaceutical Co Ltd's assets below their book value (0.57x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhangzhou Pientzehuang Pharmaceutical Co Ltd's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual total assets of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥17.56 Billion ≈ $2.57 Billion |
+0.12% |
| 2024-12-31 | CN¥17.54 Billion ≈ $2.57 Billion |
+2.69% |
| 2023-12-31 | CN¥17.08 Billion ≈ $2.50 Billion |
+16.96% |
| 2022-12-31 | CN¥14.60 Billion ≈ $2.14 Billion |
+16.87% |
| 2021-12-31 | CN¥12.50 Billion ≈ $1.83 Billion |
+22.44% |
| 2020-12-31 | CN¥10.21 Billion ≈ $1.49 Billion |
+15.83% |
| 2019-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
+32.34% |
| 2018-12-31 | CN¥6.66 Billion ≈ $974.24 Million |
+17.87% |
| 2017-12-31 | CN¥5.65 Billion ≈ $826.52 Million |
+12.12% |
| 2016-12-31 | CN¥5.04 Billion ≈ $737.19 Million |
+24.24% |
| 2015-12-31 | CN¥4.05 Billion ≈ $593.36 Million |
+11.10% |
| 2014-12-31 | CN¥3.65 Billion ≈ $534.06 Million |
+11.98% |
| 2013-12-31 | CN¥3.26 Billion ≈ $476.94 Million |
+46.11% |
| 2012-12-31 | CN¥2.23 Billion ≈ $326.43 Million |
+42.21% |
| 2011-12-31 | CN¥1.57 Billion ≈ $229.55 Million |
+8.42% |
| 2010-12-31 | CN¥1.45 Billion ≈ $211.72 Million |
+12.63% |
| 2009-12-31 | CN¥1.28 Billion ≈ $187.97 Million |
+19.99% |
| 2008-12-31 | CN¥1.07 Billion ≈ $156.65 Million |
+10.27% |
| 2007-12-31 | CN¥970.88 Million ≈ $142.07 Million |
+32.88% |
| 2006-12-31 | CN¥730.62 Million ≈ $106.91 Million |
+5.33% |
| 2005-12-31 | CN¥693.63 Million ≈ $101.50 Million |
+24.13% |
| 2004-12-31 | CN¥558.77 Million ≈ $81.77 Million |
-6.09% |
| 2003-12-31 | CN¥594.99 Million ≈ $87.07 Million |
+82.63% |
| 2002-12-31 | CN¥325.79 Million ≈ $47.67 Million |
+20.50% |
| 2001-12-31 | CN¥270.36 Million ≈ $39.56 Million |
+4.52% |
| 2000-12-31 | CN¥258.68 Million ≈ $37.85 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals… Read more